Serologic Responses to COVID-19 Vaccination in Pediatric Kidney Transplant Recipients
Additional doses of the COVID-19 vaccine bolstered durable serologic responses in pediatric kidney transplant recipients, and this study broadens our understanding of immune responses to COVID-19 vaccinations in this population.
Authors
- Kathryn Goggin (ORCID: https://orcid.org/0009-0001-0460-937X)
- Elizabeth F. Sun
- Rochelle Liverman (ORCID: https://orcid.org/0000-0001-6653-891X)
- Maria A. Perez
- Margret Kamel (ORCID: https://orcid.org/0000-0003-4126-0493)
- Andi L. Shane
- Roshan George (ORCID: https://orcid.org/0000-0003-3853-967X)
- Christina A. Rostad (ORCID: https://orcid.org/0000-0001-8439-0592)
- Evan J. Anderson (ORCID: https://orcid.org/0000-0002-1576-4420)
- Rouba Garro (ORCID: https://orcid.org/0000-0003-2936-3676)
- Langdon S. DiMaggio (ORCID: https://orcid.org/0009-0007-9196-2764)
- Hui‐Mien Hsiao
- Emily Yun
Institutions
- Emory University (US)
- Children's Healthcare of Atlanta (US)
Publication Details
- Journal
- Transplantation Direct
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1097/txd.0000000000001756
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- Emory University
- Regeneron Pharmaceuticals
- Children's Healthcare of Atlanta
- Novavax
- BioFire Diagnostics
- Moderna
- National Institutes of Health
- Sanofi Pasteur